AI-designed phage used in human patient for first time to treat drug-resistant infection

Startup Radical Numerics has announced a milestone: an AI-generated bacteriophage (a virus that infects bacteria) designed by its multimodal genomic model Omnii-1 has been used for the first time to treat a human patient's antibiotic-resistant infection—targeting a drug-resistant E. coli infection. This is the first time an AI-generated phage has entered human clinical use; according to The New York Times, it represents a customized phage therapy against a deadly bacterial infection.

Confirmed

• Radical Numerics released the Omnii-1 model, calling it "a step toward general biological intelligence"
• The Omnii-1-designed phage was used to treat a patient under compassionate use
• The company published a technical report

Not yet confirmed

• Per @exnx, the company declined to provide patient details citing confidentiality; treatment details and efficacy data have not been independently verified and currently rest on the company's own announcement

Why it matters

• Post authors widely see this as a landmark for AI for Science in synthetic biology: the first human case of an AI-designed therapy moving from experiment to clinic
• Phages can attack bacteria and hold promise for clearing drug-resistant infections, offering a new angle on antimicrobial resistance; if confirmed, it could advance the clinical pathway for AI-designed biological therapies

2026-10-20 ~ 2026-10-21 · 6 related posts

• AI-designed viruses used to treat a human patient for the first time, targeting drug-resistant E. coli — Polymarket · 2026-10-20
• [source] First-ever patient treated with AI-designed phage viruses, startup claims — exnx · 2026-10-21
• [source] Startup treats patient with AI-designed bacteriophages in a clinical first — tekbog · 2026-10-21

3 near-duplicate retellings: HazyResearch · novasarc01 · nordicinst